CSL 412Alternative Names: CSL412; CSL412 ISCOMATRIX® Flu
Latest Information Update: 21 Jul 2015
At a glance
- Originator CSL
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 31 May 2007 Phase-II clinical trials in Influenza virus infections (prevention) in United Kingdom (Parenteral)